Press Releases Press Releases Year None20202019201820172016 Date Title March 3, 2020 UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results SAN FRANCISCO , March 03, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced it will report financial results for the fourth quarter and March 2, 2020 UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer – Renowned Scientist and Drug Developer Joins UNITY’s Mission to Extend Healthspan – – Succeeds Keith Leonard Who Will Continue as Chairman – SAN FRANCISCO , March 02, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology today announced the appointment of Anirvan Ghosh , Ph.D., as CEO and member of the February 25, 2020 UNITY Biotechnology Provides Pipeline and Business Updates – Phase 2 study of UBX0101 in patients with osteoarthritis has completed enrollment – – Topline 12- and 24-week results now expected in 2H 2020 – – First patient dosed in phase 1b study to explore higher dose and repeat doses – – First-in-human study initiation for ophthalmology program expected in February 24, 2020 UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference SAN FRANCISCO , Feb. 24, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Keith Leonard , chairman and chief executive officer, Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Displaying 21 - 24 of 24
